Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-12-15 09:30 am Sale | 13D | SURROZEN INC SRZN | Consonance Capital Management LP | 0 0.000% | -6,692,999 (Position Closed) | View |
| 2022-02-14 2:45 pm Sale | 13G | ASSEMBLY BIOSCIENCES INC. ASMB | Consonance Capital Management LP | 0 0.000% | -1,969,875 (Position Closed) | View |
| 2022-02-14 1:58 pm Sale | 13G | CELLECTAR BIOSCIENCES INC CLRB | Consonance Capital Management LP | 0 0.000% | -4,703,435 (Position Closed) | View |
| 2022-02-14 1:57 pm Sale | 13G | SIO GENE THERAPIES INC SIOX | Consonance Capital Management LP | 0 0.000% | -6,058,505 (Position Closed) | View |
| 2022-02-14 1:57 pm Sale | 13G | Protagonist Therapeutics Inc PTGX | Consonance Capital Management LP | 0 0.000% | -2,729,709 (Position Closed) | View |
| 2022-02-14 1:56 pm Sale | 13G | GenMark Diagnostics Inc. GNMK | Consonance Capital Management LP | 0 0.000% | -4,480,163 (Position Closed) | View |
| 2022-02-14 1:56 pm Sale | 13G | GAMIDA CELL LTD GMDAQ | Consonance Capital Management LP | 0 0.000% | -3,287,745 (Position Closed) | View |
| 2022-02-14 1:55 pm Sale | 13G | CASI PHARMACEUTICALS HLDGS INC CASI | Consonance Capital Management LP | 0 0.000% | -7,576,431 (Position Closed) | View |
| 2022-02-14 1:52 pm Unchanged | 13G | ADMA BIOLOGICS INC ADMA | Consonance Capital Management LP | 1,558,290 1.650% | 0 (Unchanged) | View |
| 2021-09-29 11:10 am Purchase | 13D | SURROZEN INC SRZN | Consonance Capital Management LP | 6,692,999 18.400% | 1,310,499 (+24.35%) | View |
| 2021-08-18 3:33 pm Purchase | 13D | SURROZEN INC SRZN | Consonance Capital Management LP | 5,382,500 15.400% | 5,382,500 (New Position) | View |
| 2021-04-27 3:34 pm Purchase | 13D | SURROZEN INC SRZN | Consonance Capital Management LP | 1,434,000 14.900% | 1,434,000 (New Position) | View |
| 2021-02-17 3:14 pm Sale | 13G | Oxford Immunotec Global PLC OXFD | Consonance Capital Management LP | 0 0.000% | -6,058,505 (Position Closed) | View |
| 2021-02-17 3:13 pm Sale | 13G | OVID THERAPEUTICS INC OVID | Consonance Capital Management LP | 0 0.000% | -6,058,505 (Position Closed) | View |
| 2021-02-17 3:13 pm Sale | 13G | LIMINAL BIOSCIENCES INC NE LMNL | Consonance Capital Management LP | 0 0.000% | -6,058,505 (Position Closed) | View |
| 2021-02-17 3:12 pm Sale | 13G | Karyopharm Therapeutics Inc. KPTI | Consonance Capital Management LP | 0 0.000% | -6,058,505 (Position Closed) | View |
| 2021-02-17 3:12 pm Purchase | 13G | Kadmon Holdings Inc. KDMN | Consonance Capital Management LP | 7,349,621 4.290% | 514,851 (+7.53%) | View |
| 2021-02-17 3:11 pm Sale | 13G | IVERIC bio Inc. ISEE | Consonance Capital Management LP | 2,373,924 2.650% | -3,684,581 (-60.82%) | View |
| 2021-02-17 3:11 pm Sale | 13G | GenMark Diagnostics Inc. GNMK | Consonance Capital Management LP | 4,480,163 6.250% | -1,578,342 (-26.05%) | View |
| 2021-02-17 3:10 pm Sale | 13G | GAMIDA CELL LTD GMDAQ | Consonance Capital Management LP | 3,287,745 5.570% | -2,770,760 (-45.73%) | View |